Canagliflozin for Prevention of Cardiovascular and Renal Outcomes in type2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Lei Tian(Beijing University of Chinese Medicine), Yaoxian Wang(First Affiliated Hospital of Henan University), Yuzi Cai(Beijing University of Chinese Medicine), Huijuan Zheng(Inner Mongolia Agricultural University), Jingyi Tang(Beijing University of Chinese Medicine), Qian Luo(Beijing University of Chinese Medicine), Mengqi Zhou(Beijing University of Chinese Medicine), Weijing Liu(Beijing University of Chinese Medicine), Sinan Ai(Beijing University of Chinese Medicine)
Frontiers in Pharmacology
July 19, 2021
Cited by 32


Related Papers